When Fuxing, steps Switzerland and so on numerous privately operated medicine capital book struggles and buys the medical instrument the counter-its road, but the line, Hua xi the entire surface peeling medical instrument disposable trocar service attracts attention the note. Entire profession elevation of temperature As the China nat'l resources is the medicine domain important platform, China nat'l resources Wan Dong and the China nat'l resources double crane, the China nat'l resources 39, east Arab League asses' glue and the China nat'l resources commercial group constitutes the China nat'l resources is together the medical instrument, chemistry medicine, the traditional Chinese medicine and the non-prescription drug (OTC), the medicine health care, the medicine commercial five big tectonic plates. China nat'l resources Wan Dongyu announced on the other day Beijing medicine group will transfer the China nat'l resources ten thousand east 51.51% stockholder's rights, quite make field accident, because the China nat'l resources will be before this the aspect once expressed the multiplex layout medicine domain, but the medical instrument was precisely the medicine domain extends importantly the direction. In the fact, many medicine giants during maintenance tradition pharmaceutical industry's, are seeking gradually to the medicine outside the analytic continuation extend, including layout privately operated hospital and globally merger and acquisition medical instrument producer. If the Fuxing medicine last October contributed near 700,000,000 Yuan to purchase a Foshan sanchia privately operated hospital, last May purchased the Israeli medical service cosmetology instrument by 222,000,000 US dollars prices to discuss AlmaLasers. to look like in the Fuxing medicine, the privately operated Medical endoscopic linear cutter stapler establishment and the medical instrument were traditional medicine profession extending. Similarly, Shenzhen medical instrument giant steps Switzerland already repeatedly merger and acquisition international medical instrument business, if stepped Switzerland once in last June to announce that purchased the American Zonare medical system Group by 105,000,000 US dollars, afterward purchased the Australian Ulco medical service Limited company in the same year September, the latter was originally steps Switzerland in Australia's distributers, provided the innovative medical product, but was world famous.
The medical instrument line industry elevation of temperature medicine service five lacks one4/10/2014
0 Comments
Compares with the medical manufacturing industry, the medical instrument class company's growth has as if Disposable Hemorrhoids Stapler installed the engine. When up to Chinese negotiable securities newspaper reporter sending a manuscript, altogether has 4 medical instrument class To be listed to issue the wealth newspaper, these company's net profit grew compared to the same period has achieved above 25%. The profession elder brother New China medical service realizes the earning 4,194,000,000 Yuan, grows 38.15% compared to the same period; The actual ownership in parent company's net profit 2,317,000,000 Yuan, grows 41.86% compared to the same period, the company plans every 10 extensions to increase 10 and to distribute the cash bonus 1.2 Yuan. The senior medicine invests public figure Meng Linen to tell China negotiable securities newspaper reporter, the extension type expansion is the New China medical service Assassin's mace. At present company's drugs manufacture equipment, the medical instrument,disposable surgical stapler the medical service three big service tectonic plates take shape basically, future still had the possibility to continue the merger and acquisition by the rich product line. From 2012, the New China medical service fords the medical service domain, the merger and acquisition 3 hospitals, the medical service industry has become the company new profit point of growth hopefully. Among them, the visual purple ancient Chinese loses money approximately 164,000,000 Yuan, but previous year this data to gain 138,000,000 Yuan. Company the reason which loses money the achievement puts the blame on in “the Pharmaceutical company suspends production the relocation, the significant lawsuit decision and the main Disposable Endo Cutter Stapler business income reduction and so on”. in 2013 the visual purple ancient Chinese lawsuit is encumbered, now also has the lawsuit not yet to decide together. The medicine company performance abundant harvest medical instrument is sudden appearance in 2013, the medicine class To be listed achievement abundant harvest picture strikes the eye obviously, has the individual little friend to fall behind only. Up to March 13 the evening, had 30 companies to print curved cutter stapler the report card. These companies realize the business income 47,140,000,000 Yuan, the net profit 7,154,000,000 Yuan. The whole, 2013 achievement has continued 2012 steady growth situation basically. In the earning aspect, in 30 companies has 27 to realize the growth compared to the same period, occupies the ratio to reach 90%. Among them, the permanent group (13.42,0.03,0.22%), the Chinese kind pharmaceutical industry (12.520,-0.06,-0.48%), the New China medical service (93.19,0.00,0.00%), fine should manufacture drugs (21.78,0.17,0.79%) and so on 11 company compared to the same period increased ranges above 30%. The net profit aspect, some 24 realize the growth compared to the same period, occupies the ratio to reach most likely. Among them, China nat'l resources double crane (19.71,-0.28,-1.40%), Beijing new drugs manufacture, east China nat'l resources double crane, Tonghua valuable (12.75,-0.02,-0.16%) and so on 11 company's increased ranges above 30%. Especially is worth mentioning, fine should manufacture drugs completes after the Jinsha pharmaceutical curved stapler industry 64.47% stockholder's rights purchases, the profit ability promotion gets quick results, its net profit ran 1743% increased ranges, realized the net profit 139,000,000 Yuan. The company plans to all shareholder every 10 extensions to increase 10, and distributes the cash bonus 0.65 Yuan (including tax). Although the whole looks at the victory report repeatedly, but the superior permanent superior phenomenon has not had a new look, the little friend is still “the class and grade lives inferiorly”. In 7,154,000,000 Yuan net profits, east the Arab League asses' glue (37.04,-0.59,-1.57%), the China nat'l resources double crane, the China nat'l resources 39 (23.83,-0.26,-1.08%), the Conn shell (13.51,0.00,0.00%) four companies accounted for 3,700,000,000 Yuan, occupied the ratio to surpass 51%, was left over cake by in addition 26 companies carved up. Among them, east the Arab League asses' glue and the China nat'l resources 39 it may be said “double ride are above mundane thoughts”, has realized 1,200,000,000 Yuan net profits separately; The China nat'l resources double crane and the Conn shell net profit respectively is 870,000,000 and 420,000,000 Yuan. According to company's explanation, besides the east Arab League asses' glue, other three “jumbo” the achievement growth reason in the main business service's improvement, the research and development investment before this starts to march into the harvesting time, increases the new achievement point of growth. But east the Arab League asses' glue mainly relies on the main business product raises the price unceasingly guarantees the circular stapler achievement. In addition, some 6 company's net profit appears slides. The visual purple ancient Chinese (13.16,-0.05,-0.38%) slides ultra 219%; Guang Yuyuan (23.93,-0.21,-0.87%) follows, slides 105%; Day medicine stock (4.02,-0.07,-1.71%), essence drugs manufacture (17.52,-0.58,-3.20%), purple Xin pharmaceutical industry (11.65,0.11,0.95%), comfortable god (23.300,-0.22,-0.94%) slides the scope to surpass 27%. |